Corcept Therapeutics: New PROC SOC Therapy Possibility With Relacorilant Information Launch (CORT)
This text was written byComply withTerry Chrisomalis is a personal investor within the Biotech sector with ...
Read more
Tag: Therapeutics
Black Diamond Therapeutics: In Decline, However Why? (NASDAQ:BDTX)
This text was written byObserveI've my PhD in biochemistry and have labored for years analyzing medical ...
Read more
Adaptimmune therapeutics’ chief medical officer sells $3,243 in inventory By Investing.com
In a current transaction, Norry Elliot, the Chief Medical (TASE:) Officer of Adaptimmune Therapeutics PLC (NASDAQ:), ...
Read more
Kessler Topaz Meltzer & Test, LLP Notifies Traders of a Class Motion Lawsuit Towards Kyverna Therapeutics, Inc. By Investing.com
RADNOR, PA - January 14, 2025 (NEWMEDIAWIRE) - The regulation agency of Kessler Topaz Meltzer & ...
Read more
In different information this week: Coave Therapeutics secures €32M, Deciphex raises €31.4M funding, Druid Software program luggage €19.5M and extra
Expertise is ever-evolving, and on this fast-paced world, it’s difficult to cowl each story. This week ...
Read more
Sangamo Therapeutics Inventory Plunges As Pfizer Terminates Hemophilia Gene Remedy Pact
Sangamo Therapeutics Inventory Plunges As Pfizer Terminates Hemophilia Gene Remedy Pact On Monday, Sangamo Therapeutics, Inc. (NASDAQ:SGMO) ...
Read more
Viridian Therapeutics: A Clearer Image Emerges (Ranking Improve) (NASDAQ:VRDN)
This text was written byObserveBret Jensen has over 13 years as a market analyst, serving to ...
Read more
Denali Therapeutics (DNLI): A Promising Biotech With Revolutionary BBB-Crossing Expertise
kirstypargeter/iStock through Getty PicturesDenali Therapeutics Inc. (NASDAQ:DNLI) is a clinical-stage biotech growing neurodegenerative illness therapies. The ...
Read more
Lisata Therapeutics studies Q2 financials and Certepetide updates By Investing.com
Lisata Therapeutics (ticker: LSTA) has introduced a decline in working bills and a internet lack of ...
Read more
SpringWorks Therapeutics Inc. achieved full enrollment in its Section 2 trial evaluating nirogacestat By Investing.com
SpringWorks Therapeutics Inc. (SWTX) achieved full enrollment in its Section 2 trial evaluating nirogacestat SpringWorks Therapeutics, ...
Read morePremium Content
Get the latest news and follow the coverage of Business & Financial News, Stock Market Updates, Analysis, and more from the trusted sources.